Literature DB >> 7763252

Erythromycin suppresses interleukin 6 expression by human bronchial epithelial cells: a potential mechanism of its anti-inflammatory action.

H Takizawa1, M Desaki, T Ohtoshi, T Kikutani, H Okazaki, M Sato, N Akiyama, S Shoji, K Hiramatsu, K Ito.   

Abstract

We evaluated the effects of several antibiotics on IL-6 expression by human bronchial epithelial cells, potent sources of this proinflammatory cytokine important in airway inflammation. Among those tested, erythromycin (EM) and clarithromycin (CAM) uniquely suppressed mRNA levels as well as the release of IL-6 at the therapeutic and non-cytotoxic concentration (10(-6)M). Our findings suggested that these macrolide antibiotics had suppressive effect on cytokine expression in human cells, and this new mode of action may have relevance to their clinical effectiveness in airway inflammatory diseases.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7763252     DOI: 10.1006/bbrc.1995.1727

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  30 in total

Review 1.  Interference of antibacterial agents with phagocyte functions: immunomodulation or "immuno-fairy tales"?

Authors:  M T Labro
Journal:  Clin Microbiol Rev       Date:  2000-10       Impact factor: 26.132

2.  A potential role of activated NF-kappa B in the pathogenesis of euthyroid sick syndrome.

Authors:  T Nagaya; M Fujieda; G Otsuka; J P Yang; T Okamoto; H Seo
Journal:  J Clin Invest       Date:  2000-08       Impact factor: 14.808

Review 3.  Antibiotics in asthma.

Authors:  David A Beuther; Richard J Martin
Journal:  Curr Allergy Asthma Rep       Date:  2004-03       Impact factor: 4.806

4.  Clinical evaluation of macrolide-resistant Mycoplasma pneumoniae.

Authors:  Satowa Suzuki; Tsutomu Yamazaki; Mitsuo Narita; Norio Okazaki; Isao Suzuki; Tomoaki Andoh; Mayumi Matsuoka; Tsuyoshi Kenri; Yoshichika Arakawa; Tsuguo Sasaki
Journal:  Antimicrob Agents Chemother       Date:  2006-02       Impact factor: 5.191

5.  Erythromycin modulates eosinophil chemotactic cytokine production by human lung fibroblasts in vitro.

Authors:  E Sato; D K Nelson; S Koyama; J C Hoyt; R A Robbins
Journal:  Antimicrob Agents Chemother       Date:  2001-02       Impact factor: 5.191

6.  Macrolide antibiotics differentially influence human HepG2 cytotoxicity and modulate intrinsic/extrinsic apoptotic pathways in rat hepatocellular carcinoma model.

Authors:  Nagwa I Abdel-Hamid; Mona F El-Azab; Yasser M Moustafa
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2017-01-09       Impact factor: 3.000

7.  Antiangiogenic and antitumor effects of 14-membered ring macrolides on mouse B16 melanoma cells.

Authors:  J Yatsunami; Y Fukuno; M Nagata; M Tominaga; S Aoki; N Tsuruta; M Kawashima; S Taniguchi; S Hayashi
Journal:  Clin Exp Metastasis       Date:  1999-06       Impact factor: 5.150

8.  Erythromycin inhibits transcriptional activation of NF-kappaB, but not NFAT, through calcineurin-independent signaling in T cells.

Authors:  Y Aoki; P N Kao
Journal:  Antimicrob Agents Chemother       Date:  1999-11       Impact factor: 5.191

9.  Roxithromycin inhibits cytokine production by and neutrophil attachment to human bronchial epithelial cells in vitro.

Authors:  S Kawasaki; H Takizawa; T Ohtoshi; N Takeuchi; T Kohyama; H Nakamura; T Kasama; K Kobayashi; K Nakahara; Y Morita; K Yamamoto
Journal:  Antimicrob Agents Chemother       Date:  1998-06       Impact factor: 5.191

10.  Molecular mechanisms of anti-inflammatory action of erythromycin in human bronchial epithelial cells: possible role in the signaling pathway that regulates nuclear factor-kappaB activation.

Authors:  Masashi Desaki; Hitoshi Okazaki; Toshiaki Sunazuka; Satoshi Omura; Kazuhiko Yamamoto; Hajime Takizawa
Journal:  Antimicrob Agents Chemother       Date:  2004-05       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.